Audited Financial Results for the quarter and financial year ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Smruthi Organics reported FY2026 revenue of Rs 10,209 lakh, down 19% from Rs 12,610 lakh in FY2025. Net profit fell to Rs 343 lakh from Rs 356 lakh, a decline of ~3.9%, with EPS at Rs 2.99 vs Rs 3.41 prior year. PBT stood at Rs 466 lakh vs Rs 490 lakh. The company recorded an exceptional item of Rs 46.26 lakh towards estimated gratuity liability under new Labour Codes. An unmodified audit opinion was issued by Gokhale & Sathe. The Board approved a dividend of Rs 1.50 per share (15%) and appointed Ms. Smruthi Purushotham Eaga as Whole Time Director from June 2026.
Revenue contracted nearly 20% year-on-year, driven by a sharp drop in bulk drugs segment revenue; the exceptional charge further compressed profits, though operating cash flow remained healthy at Rs 2,226 lakh.